Stock listing
ERNA Stock Price, News, Filings & Events — Ernexa Therapeutics Inc.
Selected listing: ERNA · NASDAQ · USD · US
This page tracks Ernexa Therapeutics Inc.'s ERNA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ERNA:NASDAQ. ERNA:NASDAQ is the stock-level entry point for investors researching Ernexa Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ernexa Therapeutics Inc. is a public company traded under the ticker ERNA in the American market. The company has a market capitalization of approximately $4.58 million. Ernexa Therapeutics focuses on developing innovative therapeutic solutions.

- Ticker
- ERNA:NASDAQ
- Asset type
- Stock
- Market cap
- $6.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Ernexa Therapeutics Inc. ERNA:NASDAQ stock context
This page tracks Ernexa Therapeutics Inc.'s ERNA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ERNA:NASDAQ. ERNA:NASDAQ is the stock-level entry point for investors researching Ernexa Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ernexa Therapeutics Inc. is a public company traded under the ticker ERNA in the American market. The company has a market capitalization of approximately $4.58 million. Ernexa Therapeutics focuses on developing innovative therapeutic solutions.
Latest news from Ernexa Therapeutics Inc.
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 14, 2026
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
August 27, 2026
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
July 24, 2026
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Stud...
July 14, 2026
Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
June 25, 2026
Research Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc. investor report
Review AI stock analysis and investor report context for ERNA:NASDAQ.
Ernexa Therapeutics Inc. company profile
View the public company page for Ernexa Therapeutics Inc. on 6ix.
Ernexa Therapeutics Inc. news
Read company news and market updates connected to Ernexa Therapeutics Inc..
Ernexa Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Ernexa Therapeutics Inc..